• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global nuclear medicine market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global nuclear medicine market 2017 – 2021 ($ million)
o 4.2 Product Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
o 4.3 Application Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Application Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product – Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Radiotherapeutics – Market size and forecast 2022-2027
o Exhibit 34: Chart on Radiotherapeutics – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Radiotherapeutics – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Radiotherapeutics – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Radiotherapeutics – Year-over-year growth 2022-2027 (%)
o 6.4 Equipment (SPECT and PET) – Market size and forecast 2022-2027
o Exhibit 38: Chart on Equipment (SPECT and PET) – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Equipment (SPECT and PET) – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Equipment (SPECT and PET) – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Equipment (SPECT and PET) – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ million)
o Exhibit 43: Data Table on Market opportunity by Product ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 44: Chart on Application – Market share 2022-2027 (%)
o Exhibit 45: Data Table on Application – Market share 2022-2027 (%)
o 7.2 Comparison by Application
o Exhibit 46: Chart on Comparison by Application
o Exhibit 47: Data Table on Comparison by Application
o 7.3 Oncology – Market size and forecast 2022-2027
o Exhibit 48: Chart on Oncology – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Oncology – Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Oncology – Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Oncology – Year-over-year growth 2022-2027 (%)
o 7.4 Cardiology – Market size and forecast 2022-2027
o Exhibit 52: Chart on Cardiology – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Cardiology – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Cardiology – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Cardiology – Year-over-year growth 2022-2027 (%)
o 7.5 Neurology – Market size and forecast 2022-2027
o Exhibit 56: Chart on Neurology – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Neurology – Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Neurology – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Neurology – Year-over-year growth 2022-2027 (%)
o 7.6 Others – Market size and forecast 2022-2027
o Exhibit 60: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by Application
o Exhibit 64: Market opportunity by Application ($ million)
o Exhibit 65: Data Table on Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 71: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Asia – Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.5 Europe – Market size and forecast 2022-2027
o Exhibit 79: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 83: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 87: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Japan – Market size and forecast 2022-2027
o Exhibit 91: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.9 China – Market size and forecast 2022-2027
o Exhibit 95: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.10 Germany – Market size and forecast 2022-2027
o Exhibit 99: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.11 UK – Market size and forecast 2022-2027
o Exhibit 103: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ million)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 Bayer AG
o Exhibit 115: Bayer AG – Overview
o Exhibit 116: Bayer AG – Business segments
o Exhibit 117: Bayer AG – Key news
o Exhibit 118: Bayer AG – Key offerings
o Exhibit 119: Bayer AG – Segment focus
o 12.4 Bracco Spa
o Exhibit 120: Bracco Spa – Overview
o Exhibit 121: Bracco Spa – Product / Service
o Exhibit 122: Bracco Spa – Key offerings
o 12.5 Cardinal Health Inc.
o Exhibit 123: Cardinal Health Inc. – Overview
o Exhibit 124: Cardinal Health Inc. – Business segments
o Exhibit 125: Cardinal Health Inc. – Key news
o Exhibit 126: Cardinal Health Inc. – Key offerings
o Exhibit 127: Cardinal Health Inc. – Segment focus
o 12.6 Eckert and Ziegler AG
o Exhibit 128: Eckert and Ziegler AG – Overview
o Exhibit 129: Eckert and Ziegler AG – Business segments
o Exhibit 130: Eckert and Ziegler AG – Key news
o Exhibit 131: Eckert and Ziegler AG – Key offerings
o Exhibit 132: Eckert and Ziegler AG – Segment focus
o 12.7 ECZACIBASI MONROL NUCLEAR PRODUCTS CO.
o Exhibit 133: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. – Overview
o Exhibit 134: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. – Product / Service
o Exhibit 135: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. – Key offerings
o 12.8 GE Healthcare Technologies Inc.
o Exhibit 136: GE Healthcare Technologies Inc. – Overview
o Exhibit 137: GE Healthcare Technologies Inc. – Business segments
o Exhibit 138: GE Healthcare Technologies Inc. – Key offerings
o Exhibit 139: GE Healthcare Technologies Inc. – Segment focus
o 12.9 IBA Radiopharma Solutions
o Exhibit 140: IBA Radiopharma Solutions – Overview
o Exhibit 141: IBA Radiopharma Solutions – Business segments
o Exhibit 142: IBA Radiopharma Solutions – Key offerings
o Exhibit 143: IBA Radiopharma Solutions – Segment focus
o 12.10 Jubilant Pharmova Ltd.
o Exhibit 144: Jubilant Pharmova Ltd. – Overview
o Exhibit 145: Jubilant Pharmova Ltd. – Business segments
o Exhibit 146: Jubilant Pharmova Ltd. – Key news
o Exhibit 147: Jubilant Pharmova Ltd. – Key offerings
o Exhibit 148: Jubilant Pharmova Ltd. – Segment focus
o 12.11 Koninklijke Philips NV
o Exhibit 149: Koninklijke Philips NV – Overview
o Exhibit 150: Koninklijke Philips NV – Business segments
o Exhibit 151: Koninklijke Philips NV – Key news
o Exhibit 152: Koninklijke Philips NV – Key offerings
o Exhibit 153: Koninklijke Philips NV – Segment focus
o 12.12 Mallinckrodt Plc
o Exhibit 154: Mallinckrodt Plc – Overview
o Exhibit 155: Mallinckrodt Plc – Business segments
o Exhibit 156: Mallinckrodt Plc – Key news
o Exhibit 157: Mallinckrodt Plc – Key offerings
o Exhibit 158: Mallinckrodt Plc – Segment focus
o 12.13 Medi-Radiopharma
o Exhibit 159: Medi-Radiopharma – Overview
o Exhibit 160: Medi-Radiopharma – Product / Service
o Exhibit 161: Medi-Radiopharma – Key offerings
o 12.14 Necsa
o Exhibit 162: Necsa – Overview
o Exhibit 163: Necsa – Product / Service
o Exhibit 164: Necsa – Key offerings
o 12.15 Novartis AG
o Exhibit 165: Novartis AG – Overview
o Exhibit 166: Novartis AG – Business segments
o Exhibit 167: Novartis AG – Key offerings
o Exhibit 168: Novartis AG – Segment focus
o 12.16 Siemens Healthineers AG
o Exhibit 169: Siemens Healthineers AG – Overview
o Exhibit 170: Siemens Healthineers AG – Business segments
o Exhibit 171: Siemens Healthineers AG – Key news
o Exhibit 172: Siemens Healthineers AG – Key offerings
o Exhibit 173: Siemens Healthineers AG – Segment focus
o 12.17 Sirtex Medical Pty Ltd.
o Exhibit 174: Sirtex Medical Pty Ltd. – Overview
o Exhibit 175: Sirtex Medical Pty Ltd. – Product / Service
o Exhibit 176: Sirtex Medical Pty Ltd. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 177: Inclusions checklist
o Exhibit 178: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 179: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 180: Research methodology
o Exhibit 181: Validation techniques employed for market sizing
o Exhibit 182: Information sources
o 13.5 List of abbreviations
o Exhibit 183: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by Application
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global nuclear medicine market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Application Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Product – Market share 2022-2027 (%)
Exhibits31: Data Table on Product – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Radiotherapeutics – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Radiotherapeutics – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Radiotherapeutics – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Radiotherapeutics – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Equipment (SPECT and PET) – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Equipment (SPECT and PET) – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Equipment (SPECT and PET) – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Equipment (SPECT and PET) – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Data Table on Market opportunity by Product ($ million)
Exhibits44: Chart on Application – Market share 2022-2027 (%)
Exhibits45: Data Table on Application – Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Application
Exhibits47: Data Table on Comparison by Application
Exhibits48: Chart on Oncology – Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Oncology – Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Oncology – Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Oncology – Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Cardiology – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Cardiology – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Cardiology – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Cardiology – Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Neurology – Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Neurology – Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Neurology – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Neurology – Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Application ($ million)
Exhibits65: Data Table on Market opportunity by Application ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Bayer AG – Overview
Exhibits116: Bayer AG – Business segments
Exhibits117: Bayer AG – Key news
Exhibits118: Bayer AG – Key offerings
Exhibits119: Bayer AG – Segment focus
Exhibits120: Bracco Spa – Overview
Exhibits121: Bracco Spa – Product / Service
Exhibits122: Bracco Spa – Key offerings
Exhibits123: Cardinal Health Inc. – Overview
Exhibits124: Cardinal Health Inc. – Business segments
Exhibits125: Cardinal Health Inc. – Key news
Exhibits126: Cardinal Health Inc. – Key offerings
Exhibits127: Cardinal Health Inc. – Segment focus
Exhibits128: Eckert and Ziegler AG – Overview
Exhibits129: Eckert and Ziegler AG – Business segments
Exhibits130: Eckert and Ziegler AG – Key news
Exhibits131: Eckert and Ziegler AG – Key offerings
Exhibits132: Eckert and Ziegler AG – Segment focus
Exhibits133: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. – Overview
Exhibits134: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. – Product / Service
Exhibits135: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. – Key offerings
Exhibits136: GE Healthcare Technologies Inc. – Overview
Exhibits137: GE Healthcare Technologies Inc. – Business segments
Exhibits138: GE Healthcare Technologies Inc. – Key offerings
Exhibits139: GE Healthcare Technologies Inc. – Segment focus
Exhibits140: IBA Radiopharma Solutions – Overview
Exhibits141: IBA Radiopharma Solutions – Business segments
Exhibits142: IBA Radiopharma Solutions – Key offerings
Exhibits143: IBA Radiopharma Solutions – Segment focus
Exhibits144: Jubilant Pharmova Ltd. – Overview
Exhibits145: Jubilant Pharmova Ltd. – Business segments
Exhibits146: Jubilant Pharmova Ltd. – Key news
Exhibits147: Jubilant Pharmova Ltd. – Key offerings
Exhibits148: Jubilant Pharmova Ltd. – Segment focus
Exhibits149: Koninklijke Philips NV – Overview
Exhibits150: Koninklijke Philips NV – Business segments
Exhibits151: Koninklijke Philips NV – Key news
Exhibits152: Koninklijke Philips NV – Key offerings
Exhibits153: Koninklijke Philips NV – Segment focus
Exhibits154: Mallinckrodt Plc – Overview
Exhibits155: Mallinckrodt Plc – Business segments
Exhibits156: Mallinckrodt Plc – Key news
Exhibits157: Mallinckrodt Plc – Key offerings
Exhibits158: Mallinckrodt Plc – Segment focus
Exhibits159: Medi-Radiopharma – Overview
Exhibits160: Medi-Radiopharma – Product / Service
Exhibits161: Medi-Radiopharma – Key offerings
Exhibits162: Necsa – Overview
Exhibits163: Necsa – Product / Service
Exhibits164: Necsa – Key offerings
Exhibits165: Novartis AG – Overview
Exhibits166: Novartis AG – Business segments
Exhibits167: Novartis AG – Key offerings
Exhibits168: Novartis AG – Segment focus
Exhibits169: Siemens Healthineers AG – Overview
Exhibits170: Siemens Healthineers AG – Business segments
Exhibits171: Siemens Healthineers AG – Key news
Exhibits172: Siemens Healthineers AG – Key offerings
Exhibits173: Siemens Healthineers AG – Segment focus
Exhibits174: Sirtex Medical Pty Ltd. – Overview
Exhibits175: Sirtex Medical Pty Ltd. – Product / Service
Exhibits176: Sirtex Medical Pty Ltd. – Key offerings
Exhibits177: Inclusions checklist
Exhibits178: Exclusions checklist
Exhibits179: Currency conversion rates for US$
Exhibits180: Research methodology
Exhibits181: Validation techniques employed for market sizing
Exhibits182: Information sources
Exhibits183: List of abbreviations